MEHCQ (Chrome Holding Co) Other Stockholders Equity: $-0.0 Mil (As of Jun. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEHCQ Chrome Holding Co MEHCQ
58 GF Score
Price $3.50
View Full Analysis

What is Chrome Holding Co Other Stockholders Equity?

Chrome Holding Co MEHCQ -2.78% 58 Other Stockholders Equity is $-0.0 Mil as of Jun. 2025. GuruFocus rates MEHCQ with a GF Score™ of 58/100.

Chrome Holding Co's Other Stockholders Equity for the quarter that ended in Jun. 2025 was $-0.0 Mil.

Chrome Holding Co's quarterly Other Stockholders Equity declined from Dec. 2024 ($0.0 Mil) to Mar. 2025 ($-0.0 Mil) and declined from Mar. 2025 ($-0.0 Mil) to Jun. 2025 ($-0.0 Mil).

Chrome Holding Co's annual Other Stockholders Equity declined from Mar. 2023 ($0.0 Mil) to Mar. 2024 ($0.0 Mil) and declined from Mar. 2024 ($0.0 Mil) to Mar. 2025 ($-0.0 Mil).

Chrome Holding Co Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Chrome Holding Co's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chrome Holding Co Other Stockholders Equity Chart

Chrome Holding Co Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Other Stockholders Equity
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 -0.00

Chrome Holding Co Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 0.00 -0.00 -0.00 -0.00
MEHCQ
58GF Score
Chrome Holding Co MEHCQ
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chrome Holding Co Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $-0.0 Mil mean?
Chrome Holding Co (MEHCQ) has a Other Stockholders Equity of $-0.0 Mil as of Jun. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Chrome Holding Co and its competitors.
Is Chrome Holding Co's Other Stockholders Equity too high?
Chrome Holding Co's current Other Stockholders Equity is $-0.0 Mil. Overall, Chrome Holding Co has a GF Score™ of 58/100, reflecting its overall financial health beyond just this single metric.
How does Chrome Holding Co's Other Stockholders Equity compare to BDSX and XGN?
Chrome Holding Co's Other Stockholders Equity of $-0.0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Diagnostics & Research company?
A good Other Stockholders Equity depends on the Medical Diagnostics & Research industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Chrome Holding Co and its competitors. Chrome Holding Co's current Other Stockholders Equity is $-0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chrome Holding Co stock overvalued right now?
Chrome Holding Co (MEHCQ) has a current Other Stockholders Equity of $-0.0 Mil. The current Other Stockholders Equity is $-0.0 Mil. Chrome Holding Co's overall GF Score™ is 58/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Chrome Holding Co (MEHCQ), the current Other Stockholders Equity is $-0.0 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Chrome Holding Co Business Description

Address 870 Market Street, Room 415, South San Francisco, CA, USA, 94102
Chrome Holding Co, formerly known as 23andMe Holding Co, is a consumer-facing healthcare technology company, involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes one main sector that is Consumer and Research Services. The company generates maximum revenue from the Consumer and Research Services segment.
58GF Score

Get the complete analysis for MEHCQ

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.50
Price